Fresenius Medical Care (FMS)

• Market cap: $14.2B
• 1 day: -0.74%
• 5 days: 2.28%
• 1 month: -0.58%
• 3 months: 2.07%
• 6 months: 19.82%
• Year to date: 9.16%
• 1 year: 20.12%
• 5 years: -25.85%
• 10 years: -40.68%
• Sector: Healthcare
• Industry: Miscellaneous Health & Allied Services

About: Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

Employees: 113,079

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

117% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $602K

41% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 44

13% more funds holding

Funds holding: 165 [Q3] → 187 (+22) [Q4]

8% more capital invested

Capital invested by funds: $713M [Q3] → $770M (+$56.7M) [Q4]

0.18% more ownership

Funds ownership: 11.41% [Q3] → 11.59% (+0.18%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $25 3% upside
• Avg. target: $25 3% upside
• High target: $25 3% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Truist Securities David Macdonald 57% 1-year accuracy 54 / 94 met price target

3% upside $25

Hold Maintained

6 Jan 2025